Breaking News Instant updates and real-time market news.

SAVE

Spirit Airlines

$50.98

-0.64 (-1.24%)

, LOXO

Loxo Oncology

$152.74

-0.22 (-0.14%)

09:13
11/27/18
11/27
09:13
11/27/18
09:13

Fly Intel: Pre-market Movers

HIGHER: Spirit Airlines (SAVE), up 12% after increasing Q4 guidance... Loxo Oncology (LOXO), up 1% after the FDA granted accelerated approval to Vitrakvi, or larotrectinib, a treatment for adult and pediatric patients whose cancers have a specific genetic feature... Diamondback Energy (FANG), up 2.5% after being chosen to enter the S&P 500 index... Maxim (MXIM), up 4.5% after being selected to enter the S&P 500 index. UP AFTER EARNINGS: Cracker Barrel (CBRL), up 1%. DOWN AFTER EARNINGS: Hibbett Sports (HIBB), down 5%... Ferroglobe (GSM), down 39%. ALSO LOWER: United Technologies (UTX), down 2% after announcing its intention to split into 3 companies in 2022... Amarin (AMRN), down 8% after its roughly 11M share spot secondary offering priced at $18 per share.

SAVE

Spirit Airlines

$50.98

-0.64 (-1.24%)

LOXO

Loxo Oncology

$152.74

-0.22 (-0.14%)

FANG

Diamondback Energy

$109.22

4.34 (4.14%)

MXIM

Maxim Integrated

$53.36

0.57 (1.08%)

CBRL

Cracker Barrel

$175.33

1.93 (1.11%)

HIBB

Hibbett Sports

$17.95

0.7 (4.06%)

BKE

The Buckle

$20.88

0.49 (2.40%)

GSM

Ferroglobe

$4.77

0.105 (2.25%)

UTX

United Technologies

$127.99

-1.05 (-0.81%)

AMRN

Amarin

$19.39

0.26 (1.36%)

  • 27

    Nov

  • 27

    Nov

  • 27

    Nov

  • 27

    Nov

  • 27

    Nov

  • 27

    Nov

  • 27

    Nov

  • 29

    Nov

  • 29

    Nov

  • 05

    Dec

  • 27

    Nov

SAVE Spirit Airlines
$50.98

-0.64 (-1.24%)

11/27/18
SPHN
11/27/18
NO CHANGE
Target $64
SPHN
Overweight
Spirit Airlines guidance shows company executing well, says Stephens
After Spirit Airlines updated its Q4 guidance ahead of a conference presentation, Stephens analyst Jack Atkins said the update was positive from both a revenue and a cost standpoint and noted that this will be the company's third consecutive quarter of material outperformance versus expectations. He believes this underscores how Spirit is both executing well and capitalizing on solid underlying market trends. Atkins keeps an Overweight rating and $64 price target on Spirit Airlines shares.
10/30/18
10/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. LabCorp (LH) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg saying the company is faced with pressure from "lower lab testing payment rates mandated by the Protecting Access to Medicaid Act of 2014" along with business disruptions and the impact of acquisitions which resulted in lowers margins for the quarter. 2. E-Trade (ETFC) downgraded to Outperform from Strong Buy at Raymond James with analyst Patrick O'Shaughnessy saying the recent board decision not to sell the business and remain a standalone company takes a sales scenario off the table. The analyst remains positive on shares ans believes there is plenty of upside as management executes on its operating plan. 3. Southwest (LUV) downgraded to Underweight from Neutral at JPMorgan while United Continental (UAL) and Spirit Airlines (SAVE) downgraded to Neutral from Overweight. 4. Flex (FLEX) downgraded to Hold from Buy at Argus with analyst Jim Kelleher citing the expected impact from the "shutdown of Mexican operations with key customer Nike (NKE), which he expects to be fully unwound," as well as the retirement of the company CEO Mike McNamara who had presided over the company's business expansion. 5. Elevate Credit (ELVT) downgraded to Market Perform from Outperform at JMP Securities and William Blair. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/12/18
GSCO
11/12/18
INITIATION
Target $61
GSCO
Neutral
Spirit Airlines initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Catherine O'Brien started Spirit Airlines with a Neutral rating and $61 price target. The analyst expects the company's 2019 margin will be essentially flat year-over-year. She also launched coverage on the U.S. Airlines sector with an Attractive coverage view. Stronger revenue trends in 2019 coupled with a focus on cost control should drive higher industry operating margins for the first time since 2015 despite fuel headwinds, O'Brien tells investors in a research note.
11/19/18
FBCO
11/19/18
INITIATION
Target $59
FBCO
Neutral
Spirit Airlines initiated with a Neutral at Credit Suisse
Credit Suisse analyst Jose Caiado started Spirit Airlines with a Neutral rating and $59 price target. The analyst believes the company's "sustainable" cost advantage relative to peers, which is driving "solid" margin and earnings growth, is partially reflected in the current valuation.
LOXO Loxo Oncology
$152.74

-0.22 (-0.14%)

11/14/18
RAJA
11/14/18
INITIATION
Target $235
RAJA
Strong Buy
Loxo Oncology initiated with a Strong Buy at Raymond James
Raymond James initiated Loxo Oncology with a Strong Buy and $235 price target.
11/27/18
MSCO
11/27/18
NO CHANGE
Target $208
MSCO
Overweight
Loxo approval expected, pricing higher than expected, says Morgan Stanley
Morgan Stanley analyst Matthew Harrison noted that Loxo Oncology's (LOXO) Vitrakvi was approved with a broad label, as expected. Reuters reported, citing Bayer's (BAYRY) VP of pricing and contracting, that Vitrakvi will be priced at $32,800/month. Assuming a real-world ORR of about 70%, he estimates net annualized pricing of about $300,000/patient, which Harrison said is 50% above his expectation and he would expect a similar amount above consensus. The analyst, who thinks the upside pricing makes consensus estimates "very achievable" for 2019, keeps an Overweight rating on Loxo shares, which he expects will be up "modestly" on the news.
10/22/18
PIPR
10/22/18
NO CHANGE
Target $200
PIPR
Overweight
Loxo 'highly likely' to win FDA approval next month, says Piper Jaffray
Loxo Oncology (LOXO) this weekend reported updated durability data for the original 55 TRK fusion patients treated with larotrectinib plus initial efficacy data from 54 newly-evaluable patients, Piper Jaffray analyst Tyler Van Buren tells investors in a research note. He points out that the new patient dataset displayed a nearly identical response rate and that duration is tracking similarly with three quarters of patients maintaining a response out to a year. The updated larotrectinib data compare well to Roche's (RHHBY) competing entrectinib and makes the drug "highly likely" to be approved on or by the November 26 FDA action date, contends Van Buren. He reiterates an Overweight rating on Loxo Oncology with a $200 price target.
11/27/18
PIPR
11/27/18
NO CHANGE
Target $200
PIPR
Overweight
Loxo gets approval as expected, no surprise on label, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren says Vitrakvi was approved last night as expected with no surprises on the label. The analyst believes the value-based pricing model is reasonable at $32,800 per month, but only for patients who respond, and roughly in-line with current expectations for net pricing. He currently models worldwide Vitrakvi/LOXO-195 combined sales approaching $1B by the mid-to-late 2020s. Van Buren keeps an Overweight rating on Loxo Oncology with a $200 price target.
FANG Diamondback Energy
$109.22

4.34 (4.14%)

10/29/18
IFSG
10/29/18
INITIATION
Target $161
IFSG
Strong Buy
Diamondback Energy initiated with a Strong Buy at IFS Securities
IFS Securities analyst Eli Kantor started Diamondback Energy with an Outperform rating and $161 price target. The company's "long track record of outstanding execution" bodes well for future acquisition-related synergies, Kantor tells investors in a research note. The analyst believes Diamondback's "size, scale, and an equity currency advantage provide multiple ways to win through consolidation."
10/29/18
IFSG
10/29/18
INITIATION
IFSG
Strong Buy
Diamondback Energy initiated with a Strong Buy at IFS Securities
10/02/18
OPCO
10/02/18
INITIATION
OPCO
Outperform
Diamondback Energy initiated with an Outperform at Oppenheimer
Oppenheimer analyst Tim Rezvan initiated Diamondback Energy with an Outperform rating and $166 price target, calling the "best-in-breed Permian operator" one of the firm's Top Picks based on conviction.
09/27/18
PIPR
09/27/18
INITIATION
Target $174
PIPR
Overweight
Diamondback Energy assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Ryan Todd assumed coverage of Diamondback Energy with an Overweight rating and a $174 price target, calling the stock his top pure-play pick.
MXIM Maxim Integrated
$53.36

0.57 (1.08%)

10/18/18
GSCO
10/18/18
UPGRADE
Target $305
GSCO
Conviction Buy
Semi re-stack puts Nvidia on Goldman Conviction List with 25% upside
Goldman Sachs analyst Toshiya Hari this morning added Buy-rated Nvidia (NVDA) to his firm's Conviction List while lowering his price target for the shares to $305 from $324. The stock in morning trading is up 85c to $243.91. Following a "significant correction" in the stock's valuation, the analyst expects Nvidia's "idiosyncratic growth drivers," like its product cycle in Gaming and potential share gains in Data Center, to drive share outperformance. While lowering his January quarter earnings per share estimate to $1.90 from $2.28 to reflect potential volume and average selling price weakness in the Gaming business, Hari recommends investors to buy the stock at current levels with his long-term thesis intact. He sees potential upside of 25% for Nvidia shares. Positive earnings revisions post the Q3 earnings report should serve as a positive catalyst for the stock, contends the analyst. Putting Nvidia on his firm's Conviction List was part of Hari's rating re-stack in the Semiconductors sector. Also this morning, the analyst downgraded both Analog Devices (ADI) and Maxim Integrated Products (MXIM) to Sell from Neutral, downgraded Teradyne (TER) to Neutral from Buy, upgraded both Keysight Technologies (KEYS) and NXP Semiconductors (NXPI) to Buy from Neutral, and upgraded Texas Instruments (TXN) to Neutral from Sell. Hari also maintained a Conviction List Buy rating on Xilinx (XLNX) and a Sell rating on Intel (INTC).
10/31/18
LOOP
10/31/18
NO CHANGE
Target $59
LOOP
Buy
Maxim Integrated price target lowered to $59 from $70 at Loop Capital
Loop Capital analyst Cody Acree lowered his price target on Maxim Integrated to $59 after its in-line Q1 results and below-consensus outlook for the following quarter. The analyst notes that the commentary suggesting slower demand through October is similar to that of the other broad analog chip companies, with much of the weakness centered in the company's industrial segment. Acree also keeps his Buy rating on Maxim Integrated longer term, stating that it's "well positioned to weather a period of softer demand with company-specific drivers that should allow it to perform toward the high end of the sector".
10/31/18
JEFF
10/31/18
NO CHANGE
Target $60
JEFF
Buy
Maxim Integrated should be bought on guidance selloff, says Jefferies
In a post-earnings research note partially titled "Buy the Confession," Jefferies analyst Mark Lipacis recommends using the pullback today in shares of Maxim Integrated Products as a buying opportunity. The company's September quarter met expectations while its December quarter outlook did not, Lipacis writes. He points out that Semis often underperform for six months before, and outperform shortly after, the first guidance cut. Maxim underperformed the S&P 500 Index by 2,000 basis points since March, and expects December quarter earnings to miss consensus by 15%, "so we think MXIM fits this pattern," says the analyst. Further, he thinks a 25% increase to its capital return plan "should also help the stock." Lipacis lowered his price target for Maxim Integrated to $60 from $68 and keeps a Buy rating on the name.
10/31/18
RHCO
10/31/18
NO CHANGE
Target $51
RHCO
Hold
Maxim Integrated price target lowered to $51 from $60 at SunTrust
SunTrust analyst William Stein lowered his price target on Maxim Integrated to $51 and kept his Hold rating, saying the company has acknowledged the start of the downturn with a lower guided Q4 following an in-line set of results in Q3. The analyst notes that the impact of the trade tariffs are starting to emerge - particularly on the industrial end market - adding that his stock-specific concerns around consumer exposure and high valuation also remain.
CBRL Cracker Barrel
$175.33

1.93 (1.11%)

11/26/18
WELS
11/26/18
NO CHANGE
Target $157
WELS
Market Perform
Cracker Barrel price target raised to $157 from $139 at Wells Fargo
Wells Fargo analyst Jon Tower raised his price target for Cracker Barrel to $157 from $139 as he thinks Q1 top and bottom-line results will likely come in better-than-feared due in part to a much stronger than expected industry backdrop. Nonetheless, the analyst does not think this is lost on investors, as the stock is one of the best performers within the restaurant space over the trailing 3 months. Furthermore, Tower remains worried that the company has not moved fast enough from a menu and service standpoint to address the growing millennial age cohort while simultaneously leaking traffic from the boomer age cohort. He reiterates a Market Perform rating on the shares.
10/18/18
GDHS
10/18/18
INITIATION
GDHS
Hold
Cracker Barrel initiated with a Hold at Gordon Haskett
Gordon Haskett analyst Jeff Farmer initiated Cracker Barrel with a Hold rating and $152 price target, citing margin pressure and decelerating SSS being offset by a healthy dividend yield.
11/20/18
MAXM
11/20/18
DOWNGRADE
MAXM
Hold
Cracker Barrel downgraded to Hold from Buy at Maxim
Maxim analyst Stephen Anderson downgraded Cracker Barrel to Hold from Buy.
11/20/18
MAXM
11/20/18
DOWNGRADE
Target $175
MAXM
Hold
Cracker Barrel downgraded to Hold at Maxim on valuation
As reported earlier, Maxim analyst Stephen Anderson downgraded Cracker Barrel to Hold from Buy and kept his price target at $175, citing the rally in its stock price ahead of the company's earnings next week. The analyst backs his expected Q4 EPS view of $1.95, which is higher than $1.90 consensus, but also sees "flattish comps for the quarter" and only a "gradual" top-line acceleration in the remaining quarters of FY19. Anderson adds that the anticipated rebound in FY20 EPS is likely already factored into the Cracker Barrel stock price.
HIBB Hibbett Sports
$17.95

0.7 (4.06%)

10/25/18
SUSQ
10/25/18
DOWNGRADE
Target $15
SUSQ
Neutral
Hibbett Sports downgraded to Neutral at Susquehanna
As reported previously, Susquehanna analyst Sam Poser downgraded Hibbett Sports to Neutral from Positive. The analyst believes the company will miss the low end of guidance and Q3 consensus estimates. He also said distribution costs related to digital, and occupancy costs, will likely remain elevated due to poor brick and mortar store performance. Poser lowered his price target to $15 from $25 on Hibbett Sports shares.
08/27/18
08/27/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. U.S. Steel (X) double downgraded to Underweight from Overweight at Morgan Stanley with analyst Piyush Sood saying steel prices are falling and he believes the recent price peak is "firmly behind" the market. Sood lowered his price target on U.S. Steel shares to $30 from $44. 2. Chipotle (CMG) downgraded to Underperform from Neutral at Wedbush with analyst Nick Setyan saying he sees increased risk to Chipotle's near-term same-store-sales growth and margin expectations, and continues to see risk to margin expectations through 2020. Setyan lowered his price target for the shares to $445 from $450. 3. American Eagle (AEO) downgraded to Neutral from Outperform at Wedbush with analyst Jen Redding citing valuation. 4. Oasis Midstream Partners (OMP) downgraded to Neutral from Overweight at JPMorgan with analyst Jeremy Tonet citing valuation. 5. Hibbett Sports (HIBB) downgraded to Hold from Buy at Canaccord with analyst Camilo Lyon saying he sees higher expense growth and "lackluster" comps dampening the company's growth prospects following Friday's Q2 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/18
BARD
10/30/18
NO CHANGE
BARD
Hibbett Sports acquisition of City Gear bolsters urban presence, says Baird
Baird analyst Peter Benedict maintained a Neutral rating on Hibbet Sports. The analyst believes the planned acquisition of City Gear will bolster the company's presence among the younger fashion- forward customers in urban areas, and that the strategic rationale of the transaction makes sense as City Gear is expected to be accretive to EPS next year. However, the analyst also sees "stemming the decline in store comps and EBIT margins at the core-HIBB banner" as a key for the stock, and said visibility on that front was "still low."
10/25/18
SUSQ
10/25/18
DOWNGRADE
SUSQ
Neutral
Hibbett Sports downgraded to Neutral from Positive at Susquehanna
BKE The Buckle
$20.88

0.49 (2.40%)

08/20/18
DBAB
08/20/18
NO CHANGE
Target $175
DBAB
Buy
Deutsche Bank says 'sticking with' off-price, athletic brands in apparel space
Deutsche Bank analyst Paul Trussell previewed earnings for apparel companies, telling investors in a research note that he is "sticking with" off-price, the brands and athletic brands over specialty retailers and department stores. Trussell expects beats from Burlington Stores (BURL), Ross Stores (ROST), TJX (TJX), PVH (PVH), Foot Locker (FL) and Lululemon (LULU), along with American Eagle Outfitters (AEO) and Buckle (BKE) as the outliers in the specialty group and Kohl's (KSS), and says he is "a bit more cautious" for the frest of his apparel coverage given stretched valuations. Trussell raised his price target for Burlington Stores to $175 from $167, to $96 from $91 for Ross and to $105 from $100 fro TJX, but cut his price target to $171 from $176 for PVH.
11/02/18
DBAB
11/02/18
UPGRADE
Target $19
DBAB
Hold
The Buckle upgraded to Hold from Sell at Deutsche Bank
Deutsche Bank analyst Tiffany Kanaga upgraded The Buckle to Hold with an unchanged price target of $19. The analyst views the risk/reward as more balanced following the recent pullback in the shares.
GSM Ferroglobe
$4.77

0.105 (2.25%)

03/26/18
JPMS
03/26/18
UPGRADE
Target $13.5
JPMS
Overweight
Ferroglobe upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Michael Gambardella upgraded Ferroglobe to Overweight while lowering his price target for the shares to $13.50 from $18. The analyst reduced his estimates to reflect lower silicon metal prices but views Friday's selloff as "excessive." The stock on Friday closed down 24%, or $3.44, to $11.08 after the U.S. International Trade Commission determined that the imports of silicon metal from Australia and Brazil, Norway and Kazakhstan are not causing material injury to the U.S. silicon metal industry.
08/16/18
JEFF
08/16/18
NO CHANGE
Target $10
JEFF
Buy
Ferroglobe 'absolutely not considering a sale,' says Jefferies
After speaking with Ferroglobe management, Jefferies analyst Martin Englert reported that they "are absolutely not considering a sale" and continue to see value in the company's shares. The company must wait until after its Q2 report next week before it would be able to initiate a buyback, added Englert. He also believes Ferroglobe will show supply-side discipline by curtailing production and/or idling silicon metal capacity should spot prices drift lower. As a result of a reduced 2019 EBITDA forecast due to lower price assumptions, Englert lowered his price target on Ferroglobe shares to $10 from $15 but he maintains a Buy rating on the stock.
11/27/18
11/27/18
DOWNGRADE

Perform
Ferroglobe downgraded to Perform following quarterly results at Oppenheimer
As previously reported, Oppenheimer analyst Ian Zaffino downgraded Ferroglobe to Perform from Outperform following a "significantly" worse-than-expected quarter. Results for Q3 were significantly below expectations, he notes.
11/27/18
OPCO
11/27/18
DOWNGRADE
OPCO
Perform
Ferroglobe downgraded to Perform from Outperform at Oppenheimer
UTX United Technologies
$127.99

-1.05 (-0.81%)

10/24/18
RBCM
10/24/18
NO CHANGE
Target $148
RBCM
Outperform
United Technologies price target lowered to $148 from $161 at RBC Capital
RBC Capital analyst Deane Dray lowered his price target on United Technologies (UTX) to $148 to reflect his updated model of an anticipated 3-way break-up "dis-synergies" after the completion of its Rockwell Collins (COL) deal, with the Board having indicated its intentions to review the portfolio in 2-6 weeks. The analyst keeps his Outperform rating however after the company's "solid" Q3 beat which offset the "ongoing challenges at Otis" and demonstrated that tariff-related risk is "manageable".
10/17/18
10/17/18
NO CHANGE

UTC Aerospace Systems announces 5-year agreement with Wizz Air
UTC Aerospace Systems, a unit of United Technologies, announced a five-year agreement with Wizz Air to provide thrust reverser overhaul services for the airline's fleet of Airbus A320ceo aircraft. This agreement builds upon the company's history of providing maintenance, overhaul and repair services to carriers around the world.
10/25/18
10/25/18
UPGRADE
Target $112

Overweight
Ingersoll-Rand upgraded to Overweight at KeyBanc
As previously reported, KeyBanc analyst Jeffrey Hammond upgraded Ingersoll-Rand (IR) to Overweight from Sector Weight, with a $112 price target, to reflect a more positive view on its premium execution, favorable late-cycle mix, and potential to benefit from a closer look into relative HVAC valuations brought to light by United Technologies' (UTX) likely spin of Carrier. Following the recent pull back, the analyst now views Ingersoll-Rand's valuation as compelling.
11/27/18
JEFF
11/27/18
NO CHANGE
Target $148
JEFF
Buy
Jefferies analysis values United Technologies at $114-$162 per share
Jefferies analyst Sheila Kahyaoglu's sum-of-the-parts analysis values United Technologies at $114-$162 per share with a midpoint of $135. The high end of a sum-of-the-parts valuation does not always materialize and there is an element of cherry picking the peer group, Kahyaoglu tells investors in a research note after United Technologies announced its "well broadcasted intention" to separate into three individual companies. Given the expected 2020 closing for the break-up the analyst views 2019 as a transition year for the company. She keeps a Buy rating on United Technologies with a $148 price target.
AMRN Amarin
$19.39

0.26 (1.36%)

11/26/18
CANT
11/26/18
NO CHANGE
Target $35
CANT
Overweight
Sales potential of Amarin's Vascepa 'underappreciated,' says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen thinks the peak sales potential of Amarin's Vascepa is "underappreciated" following what she viewed as overwhelmingly positive data at AHA. Therefore, upward earnings revisions to levels not reflected in FactSet consensus expectations should drive the company's shares higher, she argues. The analyst notes that Amarin remains on track to submit a sNDA to expand its labeling for REDUCE-IT in early 2019, with approval expected in late 2019. Chen reiterates an Overweight rating and $35 price target on the shares.
11/14/18
11/14/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Aramark (ARMK) upgraded to Outperform from Neutral at Baird analyst Andrew Wittmann citing its recent underperformance, improving free cash flow, roughly 10% earnings growth, synergy benefits, and a steadier business model. 2. CAE (CAE) upgraded to Outperform from Neutral at Macquarie. 3. TD Ameritrade (AMTD) upgraded to Overweight from Equal Weight at Morgan Stanley analyst Michael Cyprys saying he favors discount brokers in a more volatile, late cycle environment. 4. Amarin (AMRN) upgraded to Buy from Neutral at Citi with analyst Joel Beatty citing limited upside to his price target and increased investor expectations. 5. Superior Industries (SUP) upgraded to Buy from Neutral at Buckingham with analyst Glenn Chin saying Q3 results were inline with pre-announced results and the subsequent sell-off is overdone. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/18
SBSH
11/14/18
UPGRADE
Target $28
SBSH
Buy
Citi reverses recent Amarin downgrade, upgrades to Buy after 30% pullback
Citi analyst Joel Beatty upgraded Amarin to Buy from Neutral with an unchanged price target of $28. The stock closed yesterday down 22%, or $4.44, to $15.38. The analyst downgraded the shares to Neutral on November 2 citing limited upside to his price target and increased investor expectations. Beatty, however, believes the 30% pullback in Amarin shares over the past two days following the detailed Reduce-IT trial results creates an attractive entry point. The results "paint an attractive drug profile" for Vascepa, Beatty tells investors in a research note. He continues to predict the drug's peak sales will hit the multi-billions.
11/14/18
SBSH
11/14/18
UPGRADE
SBSH
Buy
Amarin upgraded to Buy from Neutral at Citi

TODAY'S FREE FLY STORIES

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

19:35
09/22/19
09/22
19:35
09/22/19
19:35
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

DB

Deutsche Bank

$7.99

-0.08 (-0.99%)

BNPQY

BNP Paribas

$0.00

(0.00%)

JNJ

Johnson & Johnson

$131.73

1.75 (1.35%)

TEVA

Teva

$7.44

-0.08 (-1.06%)

ENDP

Endo

$3.48

0.115 (3.42%)

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

ABT

Abbott

$83.56

0.35 (0.42%)

AMRX

Amneal Pharmaceuticals

$3.34

0.21 (6.71%)

MYL

Mylan

$21.01

0.03 (0.14%)

MCK

McKesson

$146.83

1.06 (0.73%)

CAH

Cardinal Health

$47.89

-0.14 (-0.29%)

ABC

AmerisourceBergen

$85.13

0.475 (0.56%)

WAB

Wabtec

$74.01

0.26 (0.35%)

CVS

CVS Health

$64.28

0.65 (1.02%)

REAL

RealReal

$17.00

0.21 (1.25%)

CMG

Chipotle

$835.17

3.67 (0.44%)

MCD

McDonald's

$209.44

-1.12 (-0.53%)

YUM

Yum! Brands

$112.31

-1.83 (-1.60%)

WEN

Wendy's

$20.77

0.22 (1.07%)

QSR

Restaurant Brands

$72.64

-1.24 (-1.68%)

CMCSA

Comcast

$46.36

-0.32 (-0.69%)

CMCSK

Comcast

$0.00

(0.00%)

DAL

Delta Air Lines

$58.63

-0.05 (-0.09%)

FANG

Diamondback Energy

$96.90

-0.45 (-0.46%)

EHC

Encompass Health

$64.41

-0.01 (-0.02%)

FB

Facebook

$189.88

-0.27 (-0.14%)

MSFT

Microsoft

$139.34

-1.74 (-1.23%)

PG

Procter & Gamble

$122.22

0.37 (0.30%)

KO

Coca-Cola

$53.90

-0.62 (-1.14%)

PEP

PepsiCo

$134.49

-0.98 (-0.72%)

CL

Colgate-Palmolive

$70.97

0.01 (0.01%)

KMB

Kimberly-Clark

$135.13

0.9 (0.67%)

K

Kellogg

$63.79

0.07 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 02

    Oct

  • 02

    Oct

  • 02

    Oct

  • 03

    Oct

  • 08

    Oct

  • 10

    Oct

  • 15

    Oct

  • 16

    Oct

  • 18

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 01

    Nov

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

BGNE

BeiGene

$135.62

2.61 (1.96%)

19:34
09/22/19
09/22
19:34
09/22/19
19:34
Hot Stocks
BeiGene announces results on Tislelizumab from ongoing clinical trials »

BeiGene announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 15

    Oct

  • 27

    Feb

CE

Celanese

$122.73

-1.06 (-0.86%)

19:24
09/22/19
09/22
19:24
09/22/19
19:24
Hot Stocks
Celanese experiences emergency incident at Clear Lake facility »

Celanese experienced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$379.33

-5.28 (-1.37%)

19:21
09/22/19
09/22
19:21
09/22/19
19:21
Periodicals
Indonesia to fault 737 Max design, oversight lapses in Lion Air crash, WSJ says »

Indonesian investigators…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

AA

Alcoa

$21.70

-0.26 (-1.18%)

19:15
09/22/19
09/22
19:15
09/22/19
19:15
Downgrade
Alcoa rating change  »

Alcoa downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

CMC

Commercial Metals

$17.94

-0.42 (-2.29%)

, SCHN

Schnitzer Steel

$23.55

-0.27 (-1.13%)

19:15
09/22/19
09/22
19:15
09/22/19
19:15
Downgrade
Alcoa downgraded to Neutral from Buy at Goldman Sachs »

Goldman Sachs analyst…

CMC

Commercial Metals

$17.94

-0.42 (-2.29%)

SCHN

Schnitzer Steel

$23.55

-0.27 (-1.13%)

AA

Alcoa

$21.70

-0.26 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

CMC

Commercial Metals

$17.94

-0.42 (-2.29%)

19:08
09/22/19
09/22
19:08
09/22/19
19:08
Downgrade
Commercial Metals rating change  »

Commercial Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHN

Schnitzer Steel

$23.55

-0.27 (-1.13%)

19:06
09/22/19
09/22
19:06
09/22/19
19:06
Downgrade
Schnitzer Steel rating change  »

Schnitzer Steel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNSR

Finisar

$24.31

1.25 (5.42%)

18:15
09/22/19
09/22
18:15
09/22/19
18:15
Hot Stocks
Finisar presents new products, technologies at ECOC 2019 »

Finisar introduced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNPQY

BNP Paribas

$0.00

(0.00%)

, DB

Deutsche Bank

$7.99

-0.08 (-0.99%)

18:04
09/22/19
09/22
18:04
09/22/19
18:04
Periodicals
Deutsche Bank nearing deal to transfer prime assets to BNP, Reuters says »

Deutsche Bank (DB) is…

BNPQY

BNP Paribas

$0.00

(0.00%)

DB

Deutsche Bank

$7.99

-0.08 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRSK

Verisk Analytics

$158.47

-0.21 (-0.13%)

18:00
09/22/19
09/22
18:00
09/22/19
18:00
Initiation
Verisk Analytics initiated at Keefe Bruyette »

Verisk Analytics assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.92

0.78 (2.10%)

, CMCSA

Comcast

$46.36

-0.32 (-0.69%)

16:58
09/22/19
09/22
16:58
09/22/19
16:58
On The Fly
Box Office Battle: 'Downton Abbey' wins weekend with $31M »

"Box Office Battle" is…

T

AT&T

$37.92

0.78 (2.10%)

CMCSA

Comcast

$46.36

-0.32 (-0.69%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$59.19

-0.19 (-0.32%)

LGF.A

Lionsgate

$9.49

-0.47 (-4.72%)

LGF.B

Lionsgate

$8.88

-0.435 (-4.67%)

DIS

Disney

$132.18

-1.14 (-0.86%)

VIAB

Viacom

$24.92

-0.28 (-1.11%)

VIA

Viacom

$26.67

-0.85 (-3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

VIVHY

Vivendi

$0.00

(0.00%)

, MDSO

Medidata

$91.77

-0.04 (-0.04%)

16:01
09/22/19
09/22
16:01
09/22/19
16:01
Periodicals
Vivendi to widen legal battle against Mediaset beyond Italy, Reuters says »

Vivendi (VIVHY) is taking…

VIVHY

Vivendi

$0.00

(0.00%)

MDSO

Medidata

$91.77

-0.04 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

15:57
09/22/19
09/22
15:57
09/22/19
15:57
Periodicals
Some WeWork board members seeing to remove Neumann as CEO, WSJ says »

A bloc of WeWork…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

15:54
09/22/19
09/22
15:54
09/22/19
15:54
Periodicals
SoftBank turns against WeWork's parent CEO, Reuters reports »

SoftBank (SFTBY), the…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIAB

Viacom

$24.92

-0.28 (-1.11%)

, VIA

Viacom

$26.67

-0.85 (-3.09%)

15:48
09/22/19
09/22
15:48
09/22/19
15:48
Hot Stocks
Viacom acquires exclusive cable rights to Seinfeld from Sony Pictures Television »

Viacom (VIAB, VIA)…

VIAB

Viacom

$24.92

-0.28 (-1.11%)

VIA

Viacom

$26.67

-0.85 (-3.09%)

SNE

Sony

$59.19

-0.19 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

PWR

Quanta Services

$37.61

-0.28 (-0.74%)

12:22
09/22/19
09/22
12:22
09/22/19
12:22
Conference/Events
Quanta Services management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

PTEN

Patterson-UTI

$9.66

0.01 (0.10%)

12:21
09/22/19
09/22
12:21
09/22/19
12:21
Conference/Events
Patterson-UTI management to meet with Stephens »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ESE

Esco Technologies

$78.44

-1.54 (-1.93%)

12:19
09/22/19
09/22
12:19
09/22/19
12:19
Conference/Events
Esco Technologies management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

CSGP

CoStar Group

$595.10

-3.87 (-0.65%)

12:16
09/22/19
09/22
12:16
09/22/19
12:16
Conference/Events
CoStar Group participates in a conference call with Stephens »

Conference call with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 13

    Nov

CNNE

Cannae Holdings

$28.05

0.875 (3.22%)

12:02
09/22/19
09/22
12:02
09/22/19
12:02
Conference/Events
Cannae Holdings management to meet with Stephens »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 13

    Nov

ANDE

Andersons

$26.28

-0.56 (-2.09%)

12:01
09/22/19
09/22
12:01
09/22/19
12:01
Conference/Events
Andersons management to meet with Stephens »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

XGN

Exagen

$18.16

-0.425 (-2.29%)

, DDOG

Datadog

$36.20

-1.26 (-3.36%)

08:40
09/22/19
09/22
08:40
09/22/19
08:40
On The Fly
Opening Day: Datadog rises over 50% in market debut »

Shares of Datadog surged…

XGN

Exagen

$18.16

-0.425 (-2.29%)

DDOG

Datadog

$36.20

-1.26 (-3.36%)

PING

Ping Identity

$19.25

-0.8 (-3.99%)

IGMS

IGM Biosciences

$21.00

-0.7 (-3.23%)

NVST

Envista

$28.80

0.75 (2.67%)

PTON

Peloton

$0.00

(0.00%)

EDR

Endeavor

$0.00

(0.00%)

OPRT

Oportun Financial

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

CSCO

Cisco

$49.59

0.38 (0.77%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 13

    Nov

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

PG

Procter & Gamble

$122.22

0.37 (0.30%)

, KO

Coca-Cola

$53.90

-0.62 (-1.14%)

08:17
09/21/19
09/21
08:17
09/21/19
08:17
Periodicals
Kellogg, Coca-Cola among staples stocks for dividends, Barron's says »

Consumer-staples stocks…

PG

Procter & Gamble

$122.22

0.37 (0.30%)

KO

Coca-Cola

$53.90

-0.62 (-1.14%)

PEP

PepsiCo

$134.49

-0.98 (-0.72%)

CL

Colgate-Palmolive

$70.97

0.01 (0.01%)

KMB

Kimberly-Clark

$135.13

0.9 (0.67%)

K

Kellogg

$63.79

0.07 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 03

    Oct

  • 08

    Oct

  • 18

    Oct

  • 22

    Oct

  • 29

    Oct

  • 01

    Nov

CMCSA

Comcast

$46.36

-0.32 (-0.69%)

, CMCSK

Comcast

$0.00

(0.00%)

08:09
09/21/19
09/21
08:09
09/21/19
08:09
Periodicals
Facebook, Microsoft among growth stocks for risky times, Barron's says »

Comcast (CMCSA), Delta…

CMCSA

Comcast

$46.36

-0.32 (-0.69%)

CMCSK

Comcast

$0.00

(0.00%)

DAL

Delta Air Lines

$58.63

-0.05 (-0.09%)

FANG

Diamondback Energy

$96.90

-0.45 (-0.46%)

EHC

Encompass Health

$64.41

-0.01 (-0.02%)

FB

Facebook

$189.88

-0.27 (-0.14%)

JNJ

Johnson & Johnson

$131.73

1.75 (1.35%)

MSFT

Microsoft

$139.34

-1.74 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 01

    Oct

  • 02

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.